ABSTRACT
As noted in prior chapters, the economic evaluation of pharmacotherapies and other health care interventions is growing in importance as the resources directed toward health care account for progressively larger portions of the budgets of governments, employers, and individuals. Making rational decisions under conditions of resource constraints requires a method for comparing alternatives across a range of outcomes, allowing a direct ranking of the costs and benefits of specific strategies for preventing or treating a particular illness.
